149 related articles for article (PubMed ID: 22549563)
1. Safety of prednisone for ocular myasthenia gravis.
Bruce BB; Kupersmith MJ
J Neuroophthalmol; 2012 Sep; 32(3):212-5. PubMed ID: 22549563
[TBL] [Abstract][Full Text] [Related]
2. Development of generalized disease at 2 years in patients with ocular myasthenia gravis.
Kupersmith MJ; Latkany R; Homel P
Arch Neurol; 2003 Feb; 60(2):243-8. PubMed ID: 12580710
[TBL] [Abstract][Full Text] [Related]
3. Ocular myasthenia gravis - How effective is low dose prednisone long term?
Verma R; Wolfe GI; Kupersmith MJ
J Neurol Sci; 2021 Jan; 420():117274. PubMed ID: 33360170
[TBL] [Abstract][Full Text] [Related]
4. Ocular myasthenia gravis: treatment successes and failures in patients with long-term follow-up.
Kupersmith MJ
J Neurol; 2009 Aug; 256(8):1314-20. PubMed ID: 19377863
[TBL] [Abstract][Full Text] [Related]
5. Ocular myasthenia gravis in an academic neuro-ophthalmology clinic: clinical features and therapeutic response.
Mittal MK; Barohn RJ; Pasnoor M; McVey A; Herbelin L; Whittaker T; Dimachkie M
J Clin Neuromuscul Dis; 2011 Sep; 13(1):46-52. PubMed ID: 22361625
[TBL] [Abstract][Full Text] [Related]
6. Response to treatment in pediatric ocular myasthenia gravis.
Xu L; Castro D; Reisch JS; Iannaccone ST
Muscle Nerve; 2020 Feb; 61(2):226-230. PubMed ID: 31650555
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and prognosis of myasthenia gravis in older people.
Evoli A; Batocchi AP; Minisci C; Di Schino C; Tonali P
J Am Geriatr Soc; 2000 Nov; 48(11):1442-8. PubMed ID: 11083321
[TBL] [Abstract][Full Text] [Related]
8. The effect of prednisone on the progression from ocular to generalized myasthenia gravis.
Monsul NT; Patwa HS; Knorr AM; Lesser RL; Goldstein JM
J Neurol Sci; 2004 Feb; 217(2):131-3. PubMed ID: 14706214
[TBL] [Abstract][Full Text] [Related]
9. Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatment.
Kupersmith MJ; Ying G
Br J Ophthalmol; 2005 Oct; 89(10):1330-4. PubMed ID: 16170126
[TBL] [Abstract][Full Text] [Related]
10. Satisfactory Response With Achieving Maintenance Low-Dose Prednisone in Generalized Myasthenia Gravis.
Abuzinadah AR; Jabari D; Jawdat O; Pasnoor M; Glenn M; Herbelin L; McVey AL; Barohn RJ; Dimachkie MM
J Clin Neuromuscul Dis; 2018 Dec; 20(2):49-59. PubMed ID: 30439750
[TBL] [Abstract][Full Text] [Related]
11. Long-term prednisone followed by thymectomy in myasthenia gravis.
Mann JD; Johns TR; Campa JF; Muller WH
Ann N Y Acad Sci; 1976; 274():608-22. PubMed ID: 1066998
[TBL] [Abstract][Full Text] [Related]
12. Childhood myasthenia gravis: clinical features and outcomes.
Sri-udomkajorn S; Panichai P; Liumsuwan S
J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S152-7. PubMed ID: 22043769
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Corticosteroid Tapering Regimens in Myasthenia Gravis: A Randomized Clinical Trial.
Sharshar T; Porcher R; Demeret S; Tranchant C; Gueguen A; Eymard B; Nadaj-Pakleza A; Spinazzi M; Grimaldi L; Birnbaum S; Friedman D; Clair B;
JAMA Neurol; 2021 Apr; 78(4):426-433. PubMed ID: 33555314
[TBL] [Abstract][Full Text] [Related]
14. Comparative effectiveness and safety of intravenous methylprednisolone and tacrolimus monotherapy in ocular myasthenia gravis with unsatisfactory prednisone responses: a retrospective study.
Zhang KY; Duan WW; Luo YB; Li Y; Hu J; Yang H
Orphanet J Rare Dis; 2024 Jan; 19(1):19. PubMed ID: 38243274
[TBL] [Abstract][Full Text] [Related]
15. Randomized Trial of Thymectomy in Myasthenia Gravis.
Wolfe GI; Kaminski HJ; Aban IB; Minisman G; Kuo HC; Marx A; Ströbel P; Mazia C; Oger J; Cea JG; Heckmann JM; Evoli A; Nix W; Ciafaloni E; Antonini G; Witoonpanich R; King JO; Beydoun SR; Chalk CH; Barboi AC; Amato AA; Shaibani AI; Katirji B; Lecky BR; Buckley C; Vincent A; Dias-Tosta E; Yoshikawa H; Waddington-Cruz M; Pulley MT; Rivner MH; Kostera-Pruszczyk A; Pascuzzi RM; Jackson CE; Garcia Ramos GS; Verschuuren JJ; Massey JM; Kissel JT; Werneck LC; Benatar M; Barohn RJ; Tandan R; Mozaffar T; Conwit R; Odenkirchen J; Sonett JR; Jaretzki A; Newsom-Davis J; Cutter GR;
N Engl J Med; 2016 Aug; 375(6):511-22. PubMed ID: 27509100
[TBL] [Abstract][Full Text] [Related]
16. Tacrolimus Improves Symptoms of Children With Myasthenia Gravis Refractory to Prednisone.
Liu C; Gui M; Cao Y; Lin J; Li Y; Ji S; Bu B
Pediatr Neurol; 2017 Dec; 77():42-47. PubMed ID: 29074055
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolate mofetil for ocular myasthenia.
Chan JW
J Neurol; 2008 Apr; 255(4):510-3. PubMed ID: 18299952
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of corticosteroids on ocular myasthenia gravis.
Kupersmith MJ; Moster M; Bhuiyan S; Warren F; Weinberg H
Arch Neurol; 1996 Aug; 53(8):802-4. PubMed ID: 8759987
[TBL] [Abstract][Full Text] [Related]
19. Cigarette Smoking and Activities of Daily Living in Ocular Myasthenia Gravis.
Gratton SM; Herro AM; Feuer WJ; Lam BL
J Neuroophthalmol; 2016 Mar; 36(1):37-40. PubMed ID: 26457691
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of prednisone for the treatment of ocular myasthenia (EPITOME): A randomized, controlled trial.
Benatar M; Mcdermott MP; Sanders DB; Wolfe GI; Barohn RJ; Nowak RJ; Hehir M; Juel V; Katzberg H; Tawil R;
Muscle Nerve; 2016 Mar; 53(3):363-9. PubMed ID: 26179124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
